PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to assist employers,…
Access more data on PBM customer satisfaction. In 2024, PSG surveyed hundreds of drug benefit decision-makers on their satisfaction with their pharmacy benefit managers (PBMs).
PSG’s PBM Customer Satisfaction Report provides the most in-depth picture of the PBM landscape today. This research equips plan sponsors with data-driven insights to proactively…
Plans must evaluate the adverse impact of the published Drug Price Negotiation Program On August 15, 2024, the Centers for Medicare and Medicaid Services (CMS)…
Three Decades of Innovation, Independence, and Expertise at PSG “Our values don’t change. They are enduring,” said PSG President Michael Lonergan in an interview celebrating…
Payers Can Optimize Health Outcomes and Cost Management for RSV Vaccination Coverage by Understanding Several Considerations With all the focus on flu and COVID-19 in…
Resources to Support Payers’ GLP-1 Strategies GLP-1s are a class of medications that can help manage type 2 diabetes and obesity. In recent years, their…
Learn more about trends in GLP-1 perceptions and coverage strategies Obesity is one of the largest public health concerns in the United States, and for…
